Stay updated on Kadcyla Plus Pertuzumab vs. Herceptin Plus Pertuzumab Clinical Trial
Sign up to get notified when there's something new on the Kadcyla Plus Pertuzumab vs. Herceptin Plus Pertuzumab Clinical Trial page.

Latest updates to the Kadcyla Plus Pertuzumab vs. Herceptin Plus Pertuzumab Clinical Trial page
- Check4 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference0.4%
- Check12 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference0.4%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in July 2025, allowing API users to provide input beforehand. Additionally, the revision number has been updated from v2.15.2 to v2.16.4.SummaryDifference0.5%
- Check78 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check85 days agoChange DetectedThe page has been updated to include new drug information related to breast cancer treatments, specifically listing several drugs such as Paclitaxel, Epirubicin, and Doxorubicin, while significant details about a previous study on trastuzumab emtansine have been removed.SummaryDifference12%
- Check100 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to Kadcyla Plus Pertuzumab vs. Herceptin Plus Pertuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Kadcyla Plus Pertuzumab vs. Herceptin Plus Pertuzumab Clinical Trial page.